Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

22 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/22/3153932/0/en/Actuate-Therapeutics-Provides-FDA-with-Updated-Clinical-Data-Package-to-Support-Planned-Regulatory-Interactions-with-FDA-and-EMA-Over-the-Coming-Months.html

11 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/11/3148863/0/en/Actuate-Therapeutics-Announces-Closing-of-17-25-Million-Public-Offering-of-Common-Stock-Including-Full-Exercise-of-Over-Allotment-Option.html

10 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/10/3147761/0/en/Actuate-Therapeutics-Announces-Pricing-of-15-0-Million-Public-Offering-of-Common-Stock.html

09 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/09/3147344/0/en/Actuate-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html

25 Aug 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/actuate-therapeutics-advances-a-new-era-in-oncology-with-potential-universal-backbone-1064578

06 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/06/3128350/0/en/Actuate-Therapeutics-To-Collaborate-with-Incyte-Corporation-and-the-University-of-Pittsburgh-on-Clinical-Trial-of-Elraglusib-in-Combination-with-Retifanlimab-and-mFOLFIRINOX-in-Pat.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE